Arbital Health raises $31 million to support value-based care contracts
The company announced last week that Arbital Health, a medical technology company focused on value-based care, has received $31 million in Series B funding.
San Francisco-based startups provide the infrastructure for payers and providers to help them manage risk-based contracts. Its platform predicts financial outcomes, measures contract performance, and other services. It also provides consulting services from the team of actuaries to help clients create and optimize risk contracts.
Arbital Health's $31 million round of turnover is led by Valtruis, including participation from existing investors Transformation Capital, Shaper Capital and Healthy Ventures. The company was founded in 2023 and raised a total of $46 million.
“Arbital Health has built something urgently needed by the healthcare industry: the critical infrastructure that empowers payers and providers to reconcile risk-based contracts with accelerated performance insights,” said Mike Spadafore, managing director of Valtruis. “By combining top actuaries in healthcare with a senior, AI-driven platform that automates complex actuarial workflows, Arbital Health is transforming how financial and performance risks are understood and managed throughout the system.”
Arbital Health co-founder and CEO Brian Overstreet said the financing will be used in several ways. It will help expand its payer-oriented capabilities and “accelerate”
Value-based care contract performance monitoring, management and settlement of all major risk models. ” he said.
He added that it will also be used to grow its actuarial team and expand its AI-powered platform.
The healthcare industry is increasingly turning to value-based care, which links payments to patient outcomes rather than the amount of services provided, as shown in the traditional fee-service model. However, research shows that while many providers are interested in value-based models, financial and administrative barriers often prevent them.
That's why Arbital Health wants to change.
“Value-based care has not been successful, and it’s not due to a lack of vision or desire,” Overstreet told Medcity News. “The complexity of risk-based contracts, data decomposition, and lack of transparency in solutions make it difficult for organizations to succeed in value-based care arrangements. There is no neutral, trusted infrastructure that centralizes contract management, provides real-time visibility, provides real-time visibility, and ensures fair judgments. This is the paid expert we offer on a central scale. Actuary.”
Ultimately, the company hopes to create “better transparency and create a better vehicle and contract framework,” Overstreet added.
Arbital Health isn't the only company trying to support value-based care. Others include grammatical health, Privia Health and Aledade.
Photo: Atibodyphoto, Getty Images
